Prof. Mefküre ERAKSOY

Metrics

Publication

130

Publication (WoS)

Publication (Scopus)

Citation (WoS)

1632

H-Index (WoS)

Citation (Scopus)

1837

H-Index (Scopus)

Citation (Scholar)

134

H-Index (Scholar)

Citation (TrDizin)

H-Index (TrDizin)

Citation (Sum Other)

Project

Thesis Advisory

Open Access

UN Sustainable Development Goals

Education

1979 - Present

Postgraduate

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey

Dissertations

1994

Post Doctorate of Medicine

ÇOCUKLUK ÇAĞINDA MİYELİN HASTALIKLARI VE MULTİPL SKLEROZ

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

1983

Expertise In Medicine

MULTİPL SKLEROZ'DA BAŞLANGIÇ YAŞI, BAŞLANGIÇ BELİRTİLERİ VE KLİNİK SEYİR TİPİNİN PROGNOZ ÜZERİNDEKİ ETKİLERİ

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

Foreign Languages

B2 Upper Intermediate

English

Research Areas

Health Sciences

Academic Positions

1987 - Present

Professor

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences

Articles

2024

1. Validity and Reliability of the Turkish Version of the Patient-Reported Impact of Spasticity Measure in Multiple Sclerosis

Yalçın G. Y., Dünya C. P., Yeni K., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., et al.

International Journal of MS Care , vol.26, no.Q3, pp.194-198, 2024 (Scopus)

2023

2. Retrospective analysis of effectiveness of fingolimod in real life setting in Turkey (REFINE)

Tuncer A., Kürtüncü M., Terzi M., UYGUNOĞLU U., Göncüoğlu C., Yüceyar A. N., et al.

Turkish Journal of Medical Sciences , vol.53, no.1, pp.323-332, 2023 (SCI-Expanded)

2022

3. Evaluation of Clinical and Radiological Characteristics of TDLs, Long-Term Follow-up Results

KİZEK Ö., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.

EUROPEAN JOURNAL OF NEUROLOGY , pp.470-471, 2022 (SCI-Expanded)

2022

4. Dimethyl Fumarate in Multiple Sclerosis Patients: A Real World Study

GÜNDÜZ T., ÖZTÜRK ERDEN S., ERAKSOY M., KÜRTÜNCÜ M.

Kocaeli Üniversitesi Sağlık Bilimleri Dergisi , vol.8, no.2, pp.129-133, 2022 (Peer-Reviewed Journal)

2022

5. Comparison of Mitoxantrone versus Cyclophosphamide Treatment in Patients with Secondary Progressive Multiple Sclerosis

GÜNDÜZ T., ÖZCAN G., ÇAKAR A., AKÇAY H. İ., ÖZDAĞ ACARLI A. N., ERAKSOY M., et al.

Dicle Tıp Dergisi , vol.49, no.1, pp.29-35, 2022 (Peer-Reviewed Journal)

2022

6. CXCL13 Levels Indicate Treatment Responsiveness to Fingolimod in MS Patients

KARAASLAN Z., KÜRTÜNCÜ M., Akcay H. I., GÜNDÜZ T., Altunrende B., Turkoglu R., et al.

EUROPEAN NEUROLOGY , vol.85, no.1, pp.69-71, 2022 (SCI-Expanded)

2022

7. A Patient with Glucose Transporter Type 1 Deficiency Syndrome: Paroxysmal Choreoathetosis and Cerebral Positron-Emission Tomography Findings

Yapici Z., Topaloglu P., Turkmen C., Eraksoy M., Zuberi S.

NEUROLOGICAL SCIENCES AND NEUROPHYSIOLOGY , vol.39, no.1, pp.53-55, 2022 (SCI-Expanded)

2021

8. Clinical and Molecular Genetic Findings of Cerebral Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

Rustemoglu B. S., Samancı B., Tepgec F., Kürtüncü M., Altunoglu U., Gündüz T., et al.

TURKISH JOURNAL OF NEUROLOGY , vol.27, no.3, pp.240-247, 2021 (ESCI, Scopus, TRDizin)

2021

9. Evaluating the effects of transcutaneous tibial nerve stimulation or pelvic floor muscle training on sexual dysfunction in female multiple sclerosis patients reporting overactive bladder

POLAT DÜNYA C., TÜLEK Z., Kurtuncu M., Gunduz T., Panicker J. N., Eraksoy M.

NEUROUROLOGY AND URODYNAMICS , vol.40, no.6, pp.1661-1669, 2021 (SCI-Expanded)

2021

10. Bruch's membrane opening-minimum rim width: An alternative OCT biomarker study for multiple sclerosis

Ozbilen K. T., Gunduz T., Kartal S. N. C., Gedik A. C., Eraksoy M., Kurtuncu M.

EUROPEAN JOURNAL OF OPHTHALMOLOGY , vol.31, pp.2141-2149, 2021 (SCI-Expanded)

2021

11. The Complex Genetic Landscape of Hereditary Ataxias in Turkey and Implications in Clinical Practice

Vural A., Simsir G., Tekgul S., Kocoglu C., Akcimen F., Kartal E., et al.

MOVEMENT DISORDERS , vol.36, pp.1676-1688, 2021 (SCI-Expanded)

2021

12. Effectiveness of the transcutaneous tibial nerve stimulation and pelvic floor muscle training with biofeedback in women with multiple sclerosis for the management of overactive bladder

POLAT DÜNYA C., TÜLEK Z., Kurtuncu M., Panicker J. N., Eraksoy M.

MULTIPLE SCLEROSIS JOURNAL , vol.27, no.4, pp.621-629, 2021 (SCI-Expanded)

2021

13. Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Yalcin G. Y., POLAT DÜNYA C., TÜLEK Z., KÜRTÜNCÜ M., ERAKSOY M.

TURKISH JOURNAL OF NEUROLOGY , vol.27, pp.31-39, 2021 (ESCI)

2020

14. Adult-onset 4H leukodystrophy: a case presentation and review of the literature

Uygun O., Gunduz T., Eraksoy M., Kurtuncu M.

ACTA NEUROLOGICA BELGICA , vol.120, no.6, pp.1461-1462, 2020 (SCI-Expanded)

2020

15. Fingolimod Therapy for Pediatric Relapsing-Remitting Multiple Sclerosis: A Real-Life Study

Ilki C. D., Gunduz T., Kurtuncu M., Yapici Z., Sencer S., Eraksoy M.

TURKISH JOURNAL OF NEUROLOGY , vol.26, no.1, pp.34-38, 2020 (ESCI)

2020

16. Validation of the Turkish version of the eight-item actionable bladder symptom screening tool in multiple sclerosis

POLAT DÜNYA C., TÜLEK Z., Vizviz G. Y., Gunduz T., Panicker J. N., Kurtuncu M., et al.

NEUROUROLOGY AND URODYNAMICS , vol.39, no.1, pp.243-252, 2020 (SCI-Expanded)

2020

17. Hypermanganesemia with Dystonia 1: A Novel Mutation and Response to Iron Supplementation

Yapici Z., Tuschl K., Eraksoy M.

MOVEMENT DISORDERS CLINICAL PRACTICE , vol.7, no.1, pp.94-96, 2020 (ESCI)

2019

18. Impact of fingolimod on CD4+T cell subset and cytokine profile of relapsing remitting multiple sclerosis patients

Kurtuncu M., Yilmaz V., Akcay H. I., Turkoglu R., Altunrende B., Cinar S., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.337, 2019 (SCI-Expanded)

2018

19. Nasu-Hakola Disease.

Samanci B., Ulukan Ç., Gündüz T., Kürtüncü M., Eraksoy M.

Neurology India , vol.66, pp.263, 2018 (SCI-Expanded)

2017

20. Clinical and genetic features of PKAN patients in a tertiary centre in Turkey

AKÇAKAYA N., Iseri S. A., BILIR B., BATTALOGLU E., TEKTURK P., GULTEKIN M. H., et al.

CLINICAL NEUROLOGY AND NEUROSURGERY , pp.34-42, 2017 (SCI-Expanded)

2017

21. Neurobrucellosis presenting with mania

Akcay H. I., Kurtuncu M., Celik S. Y., Gunduz T., Eraksoy M.

ACTA NEUROLOGICA BELGICA , vol.117, no.1, pp.373-375, 2017 (SCI-Expanded)

2017

22. Severe rebound after withdrawal of fingolimod treatment in patients with multiple sclerosis

Gunduz T., Kurtuncu M., Eraksoy M.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , vol.11, pp.1-3, 2017 (SCI-Expanded)

2017

23. EEG Findings in Patients with Rett Syndrome

Ayta S., Oge A. E., Gurses C., Yapici Z., Eraksoy M.

EPILEPSI , vol.23, no.2, pp.63-71, 2017 (ESCI)

2016

24. The Clinical and Electroencephalography Findings of Children with Pervasive Developmental Disorder

Ayta S., Gurses C., Bilgen Z. T., Kilincarslan A., Eraksoy M.

TURKISH JOURNAL OF NEUROLOGY , vol.22, no.4, pp.167-176, 2016 (ESCI)

2015

25. Turkish families with juvenile motor neuron disease broaden the phenotypic spectrum of SPG11

Iskender C., Kartal E., Akcimen F., Kocoglu C., Ozoguz A., Kotan D., et al.

NEUROLOGY-GENETICS , vol.1, no.3, 2015 (ESCI)

2015

26. Drop-out Rate of Glatiramer Acetate is Influenced by Body Mass Index in Multiple Sclerosis Patients

KÜRTÜNCÜ M., Cinar B. C., Yildiz C. S., ÇOBAN A., Pehlivan M., ERAKSOY M.

MULTIPLE SCLEROSIS JOURNAL , vol.21, no.6, pp.818, 2015 (SCI-Expanded)

2015

27. Do Steroids Trigger Mania in Multiple Sclerosis? Not Always!

Sevim S., Karakilic S., BAŞTERZİ A. D., Eraksoy M.

TURKISH JOURNAL OF NEUROLOGY , vol.21, no.2, pp.68-70, 2015 (ESCI)

2014

28. Demyelinizan Hastalığı Taklit Eden Spinal Arteriovenöz Fistül Olgusu

Shugaiv E., AYDOSELİ A., KOCASOY ORHAN E., GÜNGÖR DOĞAN İ., İZGİ A. N., ERAKSOY M.

Klinik Tıp Bilimleri , vol.7, no.1, pp.57-59, 2014 (Peer-Reviewed Journal)

2014

29. Does FMF gene exist in multiple sclerosis and contribute to the progression?

Ozaras N., Akman-Demir G., Ustek D., Eraksoy M., Abaci N., Gül A.

NEUROLOGY ASIA , vol.19, no.2, pp.235-236, 2014 (SCI-Expanded, Scopus)

2013

30. Anti-JC virus antibody prevalence in a multinational multiple sclerosis cohort

Olsson T., Achiron A., Alfredsson L., Berger T., Brassat D., Chan A., et al.

MULTIPLE SCLEROSIS JOURNAL , vol.19, no.11, pp.1533-1538, 2013 (SCI-Expanded)

2013

31. Cerebrotendinous Xanthomatosis with Cerebellar Vacuolation

Shugaiv E., Ibrahimova G., Karaaslan Z., Bozkaya A. C., Kurtuncu M., ERAKSOY M.

TURKISH JOURNAL OF NEUROLOGY , no.1, pp.39, 2013 (ESCI)

2012

32. Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study

Kappos L., Gold R., Miller D. H., MacManus D. G., Havrdova E., Limmroth V., et al.

MULTIPLE SCLEROSIS JOURNAL , vol.18, no.3, pp.314-321, 2012 (SCI-Expanded)

2011

33. Past and Present of Disease-Modifying Treatments in Multiple Sclerosis

Eraksoy M.

NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY , vol.48, pp.46-55, 2011 (SCI-Expanded)

2011

34. Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

Kappos L., Bates D., Edan G., Eraksoy M., Garcia-Merino A., Grigoriadis N., et al.

LANCET NEUROLOGY , vol.10, no.8, pp.745-758, 2011 (SCI-Expanded)

2011

35. Autoantibodies to neuronal surface antigens in thyroid antibody-positive and -negative limbic encephalitis

Tuzun E., Erdag E., Durmus H., Brenner T., Turkoglu R., Kurtuncu M., et al.

NEUROLOGY INDIA , vol.59, no.1, pp.47-50, 2011 (SCI-Expanded)

2010

36. COMPLEMENT PATHWAYS INVOLVED IN THE INFLAMMATORY CENTRAL NERVOUS SYSTEM DISORDERS

Tuzun E., Akman-demir G., Kurtuncu M., Icoz S., Birisik O., Eraksoy M.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , vol.28, no.4, 2010 (SCI-Expanded)

2009

37. Pregnancy-induced atypic demyelinating inflammatory disease Gebelikle Tetiklenen Atipik İnflamatuvar Demiyelinizan Hastalιk

Durmus H., Tüzün E., Kürtüncü M., MUTLU M., DEMIR G. A., Eraksoy M.

Noropsikiyatri Arsivi , vol.46, no.2, pp.80-83, 2009 (SCI-Expanded)

2009

38. Development of Multiple Sclerosis in Patients with Optic Neuritis: Analysis of Predictive Factors

Durmus H., Kurtuncu M., TÜZÜN E., Akalin B., Mutlu M., Demir G. A., et al.

TURKISH JOURNAL OF NEUROLOGY , no.3, pp.119-123, 2009 (ESCI)

2008

39. Elevated IL-6 levels in the cerebrospinal fluid of neuromyelitis optica patients

Tuzun E., Akman-Demir G., Icoz S., Kurtuncu M., Eraksoy M.

JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, pp.179-180, 2008 (SCI-Expanded)

2008

40. Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients

Akman-Demir G., Tuzun E., Jarius S., Icoz S., Kurtuncu M., Waters P., et al.

JOURNAL OF NEUROIMMUNOLOGY , vol.203, no.2, pp.184, 2008 (SCI-Expanded)

2008

41. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Kappos L., Gold R., Miller D. H., MacManus D. G., Havrdova E., Limmroth V., et al.

LANCET , vol.372, no.9648, pp.1463-1472, 2008 (SCI-Expanded)

2007

42. X-linked Charcot-Marie-Tooth disease and multiple sclerosis [4]

PARMAN Y., CIFTCI F., POYRAZ M., HALEFOGLU A. M., Oge A. E., ERAKSOY M., et al.

Journal of Neurology , vol.254, no.7, pp.953-955, 2007 (SCI-Expanded)

2007

43. Neurological aspects of tuberous sclerosis in relation to MRI/MR spectroscopy findings in children with epilepsy

Yapici Z., Doertcan N., Baykan B., Okan F., Dincer A., Baykal C., et al.

NEUROLOGICAL RESEARCH , vol.29, no.5, pp.449-454, 2007 (SCI-Expanded)

2007

44. Multiple sclerosis-like clinical and magnetic resonance imaging findings in human immunodeficiency virus positive-case

Coban A., Akman-Demir G., Ozsut H., Eraksoy M.

NEUROLOGIST , vol.13, no.3, pp.154-157, 2007 (SCI-Expanded)

2007

45. High interleukin-10 production is associated with anti-acetylcholine receptor antibody production and treatment response in juvenile myasthenia gravis

YAPICI Z., Tuezuen E., ALTUNAYOGLU V., ERDOGAN A., ERAKSOY M.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , vol.117, no.11, pp.1505-1512, 2007 (SCI-Expanded)

2006

46. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?

Akman-Demir G., Gul A., Gurol E., Ozdogan H., Bahar S., Oge A. E., et al.

JOURNAL OF NEUROLOGY , vol.253, no.7, pp.928-934, 2006 (SCI-Expanded)

2006

47. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis

Rudick R., Stuart W., Calabresi P., Confavreux C., Galetta S., Radue E., et al.

NEW ENGLAND JOURNAL OF MEDICINE , vol.354, no.9, pp.911-923, 2006 (SCI-Expanded)

2005

48. Çocukluk Çağı Baş ağrılarının Sınıflandırılması ve Depresyon, Anksiyete, Benlik Saygısı Ölçeklerinin Değerlendirilmesi

KOCASOY ORHAN E., Başgül S., YAPICI Z., Ş. Üneri Ö., ERAKSOY M.

Türk Nöroloji Derneği Dergisi , no.11, pp.605-610, 2005 (Peer-Reviewed Journal)

2005

49. Excitability of facial nucleus and related brain-stem reflexes in hemifacial spasm, post-facial palsy synkinesis and facial myokymia.

Oge A. E., YAYLA V., DEMIR G., ERAKSOY M.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology , vol.116, pp.1542-54, 2005 (SCI-Expanded)

2003

50. Mustafa Hayrullah Diker (1875-1950).

ERAKSOY M.

Journal of neurology , vol.250, no.12, pp.1505-1506, 2003 (SCI-Expanded)

2002

51. Bilateral demyelinating tumefactive lesions in three children with hemiparesis

Yapici Z., Eraksoy M.

JOURNAL OF CHILD NEUROLOGY , vol.17, no.9, pp.655-660, 2002 (SCI-Expanded)

2002

52. Autoreactivity to myelin antigens related to HLA associations with multiple sclerosis

Yentur S. P., AKMAN-DEMIR G., ERAKSOY M., SARUHAN-DIRESKENELI G.

Multiple Sclerosis , vol.8, no.4, pp.278-283, 2002 (SCI-Expanded)

2001

53. Paroxysmal attacks in multiple sclerosis

Tuzun E., AKMAN-DEMIR G., ERAKSOY M.

MULTIPLE SCLEROSIS , vol.7, no.6, pp.402-404, 2001 (SCI-Expanded)

2000

54. Anti-a alpha B-crystallin immunoreactivity in inflammatory nervous system diseases

CELET B., AKMAN-DEMIR G., SERDAROGLU P., Yentur S. P., TASCI B., VAN NOORT J., et al.

JOURNAL OF NEUROLOGY , vol.247, no.12, pp.935-939, 2000 (SCI-Expanded)

1999

55. The correlation between clinical stages and EEG findings of subacute panencephalitis (SSPE)

GURSES C., OZTURK A., Baykan B., GOKYIGIT A. Z., ERAKSOY M., BARLAS M. A., et al.

EPILEPSIA , vol.40, pp.69, 1999 (SCI-Expanded)

1995

56. PAROXYSMAL DYSARTHRIA AND ATAXIA IN A PATIENT WITH BEHCETS-DISEASE

AKMANDEMIR F., Eraksoy M., GURVIT I., SARUHANDIRESKENELI G., ARAL O.

JOURNAL OF NEUROLOGY , vol.242, no.5, pp.344-347, 1995 (SCI-Expanded)

Papers Presented at Peer-Reviewed Scientific Conferences

2022

1. Multipl Skleroz Hastalarında Beyin Omurilik Sıvısı Nörofilament Hafif Zincir Seviyesinin Prognostik Değeri

Demirel A., Şahin E., Gündüz T., Yılmaz V., Tüzün E., Öztürk Erden S., et al.

58. Ulusal Nöroloji Kongresi, Antalya, Turkey, 19 - 24 November 2022, pp.63, (Summary Text)

2022

2. Validity of the Turkish Version of the Actionable 8-item screening questionnaire for neurogenic bladder overactivity in multiple sclerosis

POLAT DÜNYA C., TÜLEK Z., YALÇIN G. Y., GÜNDÜZ T., Panicker J., KÜRTÜNCÜ M., et al.

11th Quadrennial Congress of the European-Association-of-Neuroscience-Nursing (EANN), Manchester, England, 19 - 22 March 2022, (Summary Text)

2021

3. Multipl Skleroz Hastalarında Dimetil Fumarat: Bir Gerçek Yaşam Çalışması

GÜNDÜZ T., Öztürk Erden S., ERAKSOY M., KÜRTÜNCÜ M.

57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

2021

4. İzole Merkezi Sinir Sistemi IgG4 ilişkili Hastalık Tanısında Yeni bir Belirteç: Beyin Omurilik Sıvısı IgG4 İndeksi

BUĞDAYCI Z. G., KİZEK Ö., GÜNDÜZ T., ERAKSOY M., KÜRTÜNCÜ M.

57. Ulusal Nöroloji Kongres, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

2021

5. Periferik Kan İmmünfenotiplemesi OSMS'yi NMOSH'den Ayırabilir mi?

KARAASLAN Z., ŞANLI E., YÜCEER H., ULUSOY C. A., KÜÇÜKALİ C. İ., TİMİRCİ KAHRAMAN Ö., et al.

57. Ulusal Nöroloji Kongresi, Antalya, Turkey, 27 November - 01 December 2021, (Summary Text)

2020

6. Multipl Sklerozda Biyobelirteç Olarak Bruch Membran Açıklığı-Minimum Rim Genişliği’nin Değerlendirilmesi

ÖZBİLEN K. T., GÜNDÜZ T., ÇUKUROVA S. N., GEDİK A. C., ERAKSOY M., KÜRTÜNCÜ M.

56. Ulusal Nöroloji Kongresi, Turkey, 28 November - 02 December 2020, (Summary Text)

2020

7. Recurrent Intracerebral Hemorrhage Due to Alemtuzumab Treatment in a Patient with Multiple Sclerosis: Case Report

Inci M., Gunduz T., Kurtuncu M., Eraksoy M.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

2020

8. Natural Course of Relapsing Tumefactive Multiple Sclerosis and Tumefactive Demyelinating Lesions

Kizek O., Dogan F. U., Gunduz T., Kurtuncu M., Eraksoy M.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

2020

9. Progressive Multifocal Leukoencephalopathy Associated with Idiopathic CD4+Lymphocytopenia in a Patient with Heterozygous STAT4 Mutation

Acarli A. N. O., Tuzer C., Gunduz T., Ismayilov R., PARILTAY E., Alpman A., et al.

Annual Meeting of the American-Academy-of-Neurology, Toronto, Canada, 25 April - 01 May 2020, vol.94, (Summary Text)

2019

10. İstanbul Tıp Fakültesi’nin Alemtuzumab Gerçek Yaşam Verisi

AYDOĞAN A., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.

55. Ulusal Nöroloji Kongresi, Antalya, Turkey, 15 November - 21 September 2019, (Summary Text)

2019

11. Long-Term Follow-Up and Results of Patients with MRI Negative Demyelinating Diseases

Kizek O., Ilki C. D., Gunduz T., Kurtuncu M., Eraksoy M.

71st Annual Meeting of the American-Academy-of-Neurology (AAN), Pennsylvania, United States Of America, 4 - 10 May 2019, vol.92, (Summary Text)

2018

12. Multiple Sklerozlu Hastalarda “Mesane Semptom Tarama Formu” Geçerlik ve Güvenirlik Çalışması

POLAT DÜNYA C., Vızvız G. Y., TÜLEK Z., KÜRTÜNCÜ M., GÜNDÜZ T., ERAKSOY M.

54. Ulusal Nöroloji Kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

2018

13. Behçet Hastalığı Zemininde Ortaya Çıkan Kronik İnflamatuar Demiyelinizan Polinöropati Olgusu

DOĞAN F. U., GÜNDÜZ T., PARMAN F. Y., ERAKSOY M., KÜRTÜNCÜ M.

54. Ulusal Nöroloji kongresi, Turkey, 30 November 2018, (Summary Text)

2018

14. Çocukluk Yaş Başlangıçlı Demiyelinizan Hastalıklarda Klinik-demografik Özellikler Ve Anti-MOG (Myelin Oligodendrosit Glikoprotein) Antikorlarının Prognoz Üzerindeki Etkilerinin Belirlenmesi

DUMAN İLKİ C., GÜNDÜZ T., TOPALOĞLU P., YAPICI Z., KÜRTÜNCÜ M., ERAKSOY M.

54. Ulusal Nöroloji Kongresi, Turkey, 30 November - 06 December 2018, (Summary Text)

2018

15. Radyolojik İzole Sendromlu Hastaların Multipl Skleroza Dönüşümünü Öngören Faktörler

ÇİFTÇİ İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.

54. Ulusal Nöroloji Kongresi, Antalya, Turkey, 30 November - 06 December 2018, (Summary Text)

2018

16. Pilot Study Evaluating The Effects Of Transcutaneous Tibial Nerve Stimulation On Urinary Symptoms In Female Patients With Multiple Sclerosis Reporting Overactive Bladder

POLAT C., TÜLEK Z., KÜRTÜNCÜ M., GÜNDÜZ T., Panicker J., ERAKSOY M.

48th Annual Meeting of the International Continence Society, PHILADELPHIA, United States Of America, 28 - 31 August 2018, (Summary Text)

2018

17. Relatıon Between Edss Bladder Functıonal System Score And Clınıcal Features In Multıple Sclerosıs

POLAT DÜNYA C., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., ERAKSOY M.

4th Congress of the European Academy of Neurology, Lisbon, Portugal, 16 - 19 June 2018, pp.1, (Full Text)

2018

18. A Patient with 4H Syndrome Who Presents in Adulthood

Uygun O., Gunduz T., Kurtuncu M., Eraksoy M.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

2018

19. The Results of Fingolimod Treatment in Children with RRMS

Ilki C. D., Eraksoy M.

70th Annual Meeting of the American-Academy-of-Neurology (AAN), Los-Angeles, Chile, 21 - 27 April 2018, vol.90, (Summary Text)

2018

20. Multipl sklerozda EDSS- Mesane fonksiyonel durumunun klinik özellikler ile ilişkisi: Retrospektif Çalışma

POLAT C., KÜRTÜNCÜ M., TÜLEK Z., GÜNDÜZ T., ERAKSOY M.

Multiple Skleroz Hemşire Sempozyumu, Gaziantep, Turkey, 24 - 25 March 2018, pp.1, (Full Text)

2017

21. Multipl skleroz gelişiminde aday biyomarkerlarin proteomiks analiz yöntemi ile belirlenmesi

TİMİRCİ KAHRAMAN Ö., KARAASLAN Z., KÜÇÜKALİ C. İ., TÜZÜN E., BAYKAL A. T., KÜRTÜNCÜ M., et al.

53. ulusal nöroloji kongres, Turkey, 24 - 30 November 2017, (Summary Text)

2017

22. Disability Progression in Multiple Sclerosis is Biphasic with Uniform Trajectory after Expanded Disability Status Score of Three

UYANIK İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.

3rd Congress of the European Academy of Neurology, Amsterdam, Netherlands, 24 - 27 June 2017, (Summary Text)

2016

23. Fingolimod Tedavisinin Multipl Skleroz hastalarında periferik kan hücre immünofenotipleri üzerine etkisi

AKÇAY H. İ., ULUSOY C. A., ÇINAR S., YILMAZ V., Türkoğlu R., Altunrende B., et al.

52. ULUSAL NÖROLOJİ KONGRESİ, Antalya, Turkey, 25 November - 01 December 2016, pp.30, (Full Text)

2016

24. Multipl Skleroz Hastalarının Doğum Ayı İle Cinsiyet Arasında Bir İlişki Var mı?

UYANIK İ., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.

52. Ulusal Nöroloji Kongresi, Tartışmalı E-poster - 121, Turkey, 25 November - 01 December 2016, (Summary Text)

2016

25. Comparison of Mitoxantrone versus Cyclophosphamide in Patients with Secondary Progressive Multiple Sclerosis

GÜNDÜZ T., ÖZCAN G., ÇAKAR A., AKÇAY H. İ., ÖZDAĞ ACARLI A. N., KÜRTÜNCÜ M., et al.

2nd Congress of European Academy of Neurology, Kopenhag, Denmark, 28 - 31 May 2016, vol.23, pp.601-879, (Summary Text)

2016

26. Detection Of Biomarkers in Cerebrospinal Fluid of Multiple Sclerosis Patients By Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS)

TİMİRCİ KAHRAMAN Ö., KÜÇÜKALİ C. İ., TÜZÜN E., KÜRTÜNCÜ M., BAYKAL A. T., ERAKSOY M.

X. Annual Congress of the European Proteomics Association, İstanbul, Turkey, 22 - 25 June 2016, pp.1-2, (Full Text)

2016

27. Adrenokorti̇kal yetersi̇zli̇kte ön planda akla gelmeyen di̇ğer etyoloji̇ler.

HACİŞAHİNOĞULLARI H., KOÇ M. S., MASTANZADE M., KUBAT ÜZÜM A., GÜNDÜZ T., KARACA M., et al.

38. Türkiye Endokrinoloji ve Metabolizma Hastalıkları Kongresi, Turkey, 11 May 2016, (Summary Text)

2016

28. The effect of fingolimod treatment on peripheral blood cell immunophenotypes in patients with multiple sclerosis

ULUSOY C. A., ÇINAR S., YILMAZ V., AKÇAY H. İ., Türkoğlu R., GÜNDÜZ T., et al.

International Molecular Immunology & Immunogenetcs Congress (MIMIC-III), Antalya, Turkey, 27 - 30 April 2016, vol.4, pp.75, (Full Text)

2016

29. Withdrawal Rebound after Fingolimod in Multiple Sclerosis Patients

Gunduz T., Kurtuncu M., Eraksoy M.

68th Annual Meeting of the American-Academy-of-Neurology (AAN), Vancouver, Canada, 15 - 21 April 2016, vol.86, (Summary Text)

2016

30. Clinical features of patients with relapsing inflammatory optic neuritis

Tuzun E., Cakar A., Akcay H. I., Kurtuncu M., Eraksoy M.

ACTRIMS Forum, Louisiana, United States Of America, 18 - 20 February 2016, vol.22, pp.20-21, (Summary Text)

2016

31. Switching From Glatiramer Acetate: Comparison of Disease Modifying Treatments

Kurtuncu M., Akcay H. I., Cakar A., Gunduz T., Tuzun E., Eraksoy M.

ACTRIMS Forum, Louisiana, United States Of America, 18 - 20 February 2016, vol.22, pp.18-19, (Summary Text)

2013

32. Uveitis as a prognostic factor in multiple sclerosis

Shugaiv E., TÜZÜN E., ÇOBAN A., Pehlivan M., KÜRTÜNCÜ M., Demir G., et al.

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 October 2013

2013

33. Üveitin Multipl Sklerozun Seyri Üzerine Etkisi

SHUGAİV E., TÜZÜN E., ÇOBAN A., PEHLİVAN M., KÜRTÜNCÜ M., DEMİR G., et al.

49. Ulusal Nöroloji Kongresi, Turkey, 11 November 2013

2014

34. Psikiyatrik Bulgularla Başlayan Nörobruselloz

AKÇAY H. İ., ÇINAR BALCIOĞLU Ç., ÇELİK Ş., ÇOBAN A., KÜRTÜNCÜ M., ERAKSOY M.

50. Ulusal Nöroloji Kongresi, Turkey, 21 November 2014

2014

35. Manyetik Rezonans İncelemesi Normal Olan Multipl Skleroz Mit mi Gerçek mi

ÇELİK Ş., ÇOBAN A., BİRDAY E., KÜRTÜNCÜ M., ERAKSOY M.

50. Ulusal Nöroloji Kongresi, Turkey, 21 November 2014

2014

36. Multipl Skleroz Hastalarının Hastalık Modifiye Edici Tedavilerde Kalma sürelerinin Karşılaştırılması

KÜRTÜNCÜ M., ÇELİK Ş., ÇOBAN A., BİRDAY E., PEHLİVAN M., DEMİR G., et al.

50. Ulusal Nöroloji Kongresi, Turkey, 21 November 2014

2014

37. Santral Sinir Sistemi Sarkoidozu 10 Hastanın Klinik Seyri

SAMANCI B., ÇELİK Ş., BİLGİÇ B., ÇOBAN A., KÜRTÜNCÜ M., ERAKSOY M.

50. Ulusal Nöroloji Kongresi, Turkey, 21 November 2014

2014

38. Multipl Skleroz Hastalarında Status Epileptikus

AKÇAY H. İ., ÇELİK Ş., ÇOBAN A., KÜRTÜNCÜ M., ERAKSOY M.

50. Ulusal Nöroloji Kongresi, Turkey, 21 November 2014

2014

39. Drop out Rate Of Glatiramer Acetate Is Influenced By Body Mass Index In Multiple Sclerosis Patients

KÜRTÜNCÜ M., BALCIOĞLU Ç., ÇELİK Ş., ÇOBAN A., PEHLİVAN M., ERAKSOY M.

7th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), 06 November 2014

2014

40. Comparison of dropout rates of disease modifying therapies in multiple sclerosis

KÜRTÜNCÜ M., ÇELİK S., ÇOBAN A., SHUGAİV E., PEHLİVAN M., DEMİR G., et al.

2014 Joint ACTRIMS-ECTRIMS Meeting, 10 September 2014

2014

41. Computer assisted cognitive rehabilitation in patients with multiple sclerosis and parenchymal neuro Behçet s disease

NUROVA B., KÜRTÜNCÜ M., ÇOBAN A., BİRDAY E., ERAKSOY M.

EFNS-ENS Joint Congress of European Neurology, 31 May - 03 June 2014

2013

42. Fingolimod in Relapsing Remitting Multiple Sclerosis: Short Term Safety Profile

Altunrende B., Shugaiv E., Yabalak A., Topcular B., Kocaslan M., Pabuscu E., et al.

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japan, 6 - 08 November 2013, vol.20, pp.928, (Summary Text)

2013

43. Mitochondrial carrier 1 (MTCH1) antibodies in neuromyelitis optica patients with or without aquaporin-4 antibodies

Coban A., Cavus F., Ulusoy C., Turan S., Vural B., Turkoglu R., et al.

6th Congress of the Pan-Asian-Committee-on-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS), Kyoto, Japan, 6 - 08 November 2013, vol.20, pp.942-943, (Summary Text)

2014

44. Coexistence of neuromyelitis optica and seizures a case report

SHUGAİV E., ÇOBAN A., KÜRTÜNCÜ M., TÜZÜN E., DEMİR G., ERAKSOY M.

EFNS-ENS Joint Congress of European Neurology, 31 May 2014

2014

45. Validity and Reliability of the Turkish Version of Multiple Sclerosis Related Symptom Scale

TÜLEK Z., POLAT C., KÜRTÜNCÜ M., ERAKSOY M.

EFNS Congress (European Federation of Neurological Societies), İstanbul, Turkey, 31 May - 03 June 2014, vol.678, (Summary Text)

2014

46. VALIDITY AND RELIABILITY OF THE TURKISH VERSION OF THE MULTIPLE SCLEROSIS-RELATED SYMPTOM SCALE

TÜLEK Z., POLAT C., KÜRTÜNCÜ M., ERAKSOY M.

EFNS-ENS Joint Congress of Neurology, İstanbul, Turkey, 30 May - 03 June 2014, pp.1, (Full Text)

2013

47. Aquaporin 1 in Turkish Neuromyelitis Optica Patients with and without Aquaporin 4 Antibodies

ÇOBAN A., Tzartos J., Stergiou C., Demir G., Zisimopoluou P., Shugaiv E., et al.

29TH Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS), 02 October 2013

2013

48. Aquaporin 1 antikoru Aquaporin 4 Antikoru pozitif olan ve olmayan Nöromyelitis Optica Hastalarında Yeni Saptanan Bir Antikor

ÇOBAN A., TZARTOS J., STERGİOU C., DEMİR G., ZİSİMOPOULOU P., SHUGAİV E., et al.

49. Ulusal Nöroloji Kongresi, Turkey, 15 November 2013

2013

49. Vibrasyon Duyusu Süresinin Normal Dğerlerinin Saptanması

KARBAY M., PEHLİVAN M., BİRDAY E., ÇOBAN A., KÜRTÜNCÜ M., ERAKSOY M.

49. Ulusal Nöroloji Kongresi, Turkey, 15 November 2013

2013

50. Multipl Sklerozda Bilgisayar Destekli Bilişsel Rehabilitasyonun Etkisi

GÖKÇEİMAM B., BİRDAY E., ÇOBAN A., GÜNDÜZ T., KÜRTÜNCÜ M., ERAKSOY M.

49. Ulusal Nöroloji Kongresi, Turkey, 11 November 2013

2013

51. Natalizumaba Bağlı Progresif Multifokal Lökoensefalopati Olgusu

ÇAKAR A., KARAASLAN Z., KARBAY M., BİRDAY E., ÇOBAN A., PEHLİVAN M., et al.

49. Ulusal Nöroloji Kongresi, Turkey, 11 November 2013

2013

52. MTCH1 antibodies in Neuromyelitis Optica patients with or without aquaporin 4 antibodies

ÇOBAN A., Çavuş F., ULUSOY C. A., Turan S., VURAL B., Türkoğlu R., et al.

Twenty-third Meeting of the European Neurological Society, 08 June 2013

2013

53. Klinik İzole Sendromdan Klinik Olarak Kesin Multipl Skleroza Dönüşüm Sürecinde MRI Ve Disabilitenin Prediktif Değeri

ARIKANOĞLU A., SHUGAİV E., ÇOBAN A., TÜZÜN E., ERAKSOY M.

6. Nöroimmünoloji Okulu, Turkey, 28 February 2013

2013

54. Novel Anti-Neuronal Antibodies in Neuromyelitis Optica Patients with or without Aquaporin-4 Antibodies

Cavus F., Ugurel E., Sehitoglu E., Woodhall M., Waters P., Ulusoy C., et al.

65th Annual Meeting of the American-Academy-of-Neurology (AAN), California, United States Of America, 16 - 23 March 2013, vol.80, (Summary Text)

2012

55. Uveitis in patients with multiple sclerosis

Shugaiv E., KÜRTÜNCÜ M., Mutlu M., Akman-Demir G., Tugal-Tutkun I., TÜZÜN E., et al.

11th International Congress of Neuroimmunology (ISNI), Massachusetts, United States Of America, 4 - 08 November 2012, pp.34, (Summary Text)

2012

56. A Case Of MRI Negative Neurobrucellosis With Isolated Spinal Cord Involvement

GÜNDÜZ T., TOPALOĞLU P., ERAKSOY M., YAPICI Z.

ICNC2012 (12th International Child Neurology Congress), Brisbane, Australia, 27 May - 01 June 2012, vol.54, pp.1-220, (Summary Text)

2012

57. Elevated Switch-Associated Protein 70 (SWAP70) Antibody Levels during Attacks in Multiple Sclerosis Patients

Erdag E., Ugurel E., Cavus F., Vural B., Kurtuncu M., Eraksoy M., et al.

64th Annual Meeting of the American-Academy-of-Neurology (AAN), Louisiana, United States Of America, 21 - 28 April 2012, vol.78, (Summary Text)

2011

58. Anti-Neuronal and Stress-Induced-Phosphoprotein 1 Antibodies in Neuro-Behcet's Disease

Akman-Demir G., Vural B., Ugurel E., Icoz S., TÜZÜN E., Kurtuncu M., et al.

63rd AAN Annual Meeting, Hawaii, United States Of America, 9 - 16 April 2011, vol.76, (Summary Text)

2010

59. Familial effects on the age of onset, initial symptoms and clinical course of multiple sclerosis

ERAKSOY M., DEMİR F. G., YAPICI Z., GÜNDÜZ T., KÜRTÜNCÜ M.

20th Meeting of the European Neurological Society, Berlin, Germany, 19 - 23 June 2010, vol.257, pp.1-246, (Summary Text)

2008

60. The effect of BG00012 on conversion of gadolinium-enhancing lesions to T1-hypointense lesions

MacManus D. G., Miller D., Kappos L., Gold R., Havrdova E., Limmroth V., et al.

13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Canada, 17 - 20 September 2008, vol.14

2008

61. Safety profile of BG00012, all oral formulation of dimethyl fumarate for patients with relapsing MS

Gold R., Kappos L., Miller D. H., Havrdova E., Limmroth V., Polman C., et al.

13th Annual Meeting of the Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/24th Congress of the European-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis/5th Congress of the Latin-Amer-Comm-for-Treatment-and-Res-in-Multiple-Sclerosis, Montreal, Canada, 17 - 20 September 2008, vol.14, (Summary Text)

2008

62. Syndrome of transient headache and neurological deficits with cerebrospinal fluid lymphocytosis: is it auto-immune?

KURTUNCU M., TUZUN E., ICOZ S., Baslo B., KAYA D., DURMUS H., et al.

18th Meeting of the European-Neurological-Society, Nice, France, 7 - 11 June 2008, vol.255, pp.216-217, (Summary Text)

2008

63. The efficacy of BG00012 in patients with relapsing-remitting multiple sclerosis: Subgroup analyses from the phase 2B study

Kappos L., Miller D., MacManus D., Gold R., Havrdova E., Limmroth V., et al.

60th Annual Meeting of the American-Academy-of-Neurology, Illinois, United States Of America, 12 - 19 April 2008, vol.70, (Summary Text)

2008

64. Devic's neuromyelitis optica: An analysis of 47 patients and prognostic implications of NMO IgG status

Akman-Demir G., ERAKSOY M., TÜZÜN E., Jarius S., Icoz S., Kartuncu M., et al.

60th Annual Meeting of the American-Academy-of-Neurology, Illinois, United States Of America, 12 - 19 April 2008, vol.70, (Summary Text)

2004

65. Multipl Skleroz Benzeri Ak Madde Lezyonları Gösteren HIV Miyelopati Olgusu

ÇOBAN A., YEŞİLOT N., DEMİR G., ERAKSOY M.

40. Ulusal Nöroloji Kongresi, Turkey, 29 September 2004

2007

66. Clinical profile in GJA12 mutations: Nine Turkish children

Yapici Z., BILIR B., Yalcinkaya C., Isoglu-Alkac U., BATTALOGLU E., Eraksoy M.

59th Annual Meeting of the American-Academy-of-Neurology, Massachusetts, United States Of America, 28 April - 05 May 2007, vol.68, (Summary Text)

2007

67. Safety and tolerability results of a phase 2b extension study of the novel oral fumarate BG00012 for the treatment of relapsing-remitting multiple sclerosis

Kappos L., Gold R., Miller D., MacManus D. G., Havrdova E., Limmroth V., et al.

59th Annual Meeting of the American-Academy-of-Neurology, Massachusetts, United States Of America, 28 April - 05 May 2007, vol.68, (Summary Text)

2006

68. Plasma cytokine levels in juvenile myasthenia gravis: 11 patients

Yapici Z., Erdogan H. A., TÜZÜN E., Vildan A., İŞSEVER H., ERAKSOY M.

11th International Congress on Neuromuscular Diseases, İstanbul, Turkey, 2 - 07 July 2006, vol.16, (Summary Text)

2005

69. Salmonella Osteomiyeliti Gelişen Bir Multipl Skleroz Olgusu

ORHAN E., ÇOBAN A., YEŞİLOT N., BASLO M. B., DEMİR G., ERAKSOY M.

41. Ulusal Nöroloji Kongresi, Turkey, 05 December 2005

2003

70. Epidural Apse Üç Olgu

BERK H., ÇAĞATAY A., ÖZSÜT H., ERAKSOY M., ÇALANGU S., ÇOBAN A., et al.

XI. Türk Klinik Mikrobiyoloji ve İnfeksiyon Hastalıkları Kongresi, Turkey, 30 March 2003

1999

71. Disability and quality of life in multiple sclerosis

YALIMAN A., ERAKSOY M., ORAL A., SİNDEL D.

AAPM&R 61st Annual Assembly and 13th World congress of the International Federation of Physical Medicine and Rehabilitation, Washington Dc, United States Of America, 11 - 14 November 1999, pp.1142, (Full Text)

Books

2006

1. South Mediterranean Meeting on Multiple Sclerosis. New Insights for clinical Practices.

Comı G. (Editor), Eraksoy M. (Editor)

FAO, Rome , Milan, 2006

1984

2. Behçet Sendromunun Nörolojik Yönleri (Sinir sistemi belirtisi gösteren 24 olgunun klinik ve laboratuvar özellikleri)

Eraksoy M., Özdemir C.

in: . I. Behçet günü (l8 Mart 1984), Saylan T,Övül C,Azizlerli G,Özarmagan G, Editor, Istanbul University, İstanbul, pp.1-72, 1984

Other Publications

2017

1. Multipl Skleroz Gelişiminde Aday Biyomarkerların Proteomiks Analiz Yöntemi ile Belirlenmesi

TİMİRCİ KAHRAMAN Ö., KÜÇÜKALİ C. İ., KARAASLAN Z., TÜZÜN E., BAYKAL A. T., KÜRTÜNCÜ M., et al.

Presentation, pp.1-2, 2017

Funded Projects

2016 - 2016

Clinical and Genetic Features of PKAN Patients in a Tertiary Center in Turkey

Project Supported by Higher Education Institutions , BAP Other

ÖZBEK U. (Executive), UĞUR İŞERİ S. A., HANAĞASI H. A., CEYLAN N. H., YAPICI Z., ERAKSOY M., et al.

2014 - 2015

Parkinson hastalığının hayvan Modelinde P13K/AKT Yolağı İle Mitokondriyel, Oksidatif ve Apoptotik Parametrelerin İlişkisi

Project Supported by Higher Education Institutions , BAP Other

ERAKSOY M. (Executive)

2000 - 2005

GENETIC ANALYSIS OF MULTIPLE SCLEROSIS IN EUROPEANS

Universities of Other Countries Supported Project

(Project Final Report)

Eraksoy M.

1994 - 1996

HLA-DR and -DQ Associations with Multiple Sclerosis in Turkey

TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects

(Project Abstract) (Project Final Report)

Eraksoy M., Saruhan Direskeneli G., Baykal B.

Memberships and Roles in Scientific Organizations

2006 - Present

INTERNATIONAL PAEDIATRIC MULTIPLE SCLEROSIS STUDY GROUP(IPMSSG)

Member

1999 - Present

AMERİKAN NÖROLOJİ AKADEMİSİ

Member

1980 - Present

TÜRK NÖROLOJİ DERNEĞİ

Member

1998 - 2014

EUROPEAN NEUROLOGICAL SOCIETY

Member

2000 - 2013

ÇOCUK VE ERGEN NÖROLOJİSİ DERNEĞİ

Chairman

2001 - 2012

NÖROİMMUNOLOJİ DERNEĞİ

Chairman

1998 - 2010

EUROPEAN PAEDIATRIC NEUROLOGY SOCIETY

Member

1993 - 2010

INTERNATIONAL FEDERATION OF MULTIPLE SCLEROSIS

Member of Science Committee

Peer Reviews in Scientific Publications

October 2020

TÜRK NÖROLOJİ DERGİSİ

National Scientific Refreed Journal

Scientific Consultations

2020 - 2020

Scientific Consultancy

GEN İLAÇ

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey

2020 - 2020

Scientific Consultancy

NOVARTİS

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey

2020 - 2020

Scientific Consultancy

ROCHE

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey

2019 - 2019

Project Consultancy

NOVARTİS

Istanbul University, Istanbul Medical Faculty, Division of Medical Sciences , Turkey